Director's Messages

The NIH HEAL Initiative and Pain Research

(Tuesday, June 12, 2018)
In last month’s NINDS Director’s message I introduced the planning stages of the NIH HEAL

Making Progress in Glioblastoma

(Wednesday, May 30, 2018)
NINDS Director Walter J. Koroshetz and NCI Director Norman E. Sharpless

The NINDS R35 Program: An innovation experiment

(Tuesday, May 15, 2018)
NIH relies heavily on investigator-initiated R01 grants to fuel its science. This democratic approach is responsible in large part for the success of the American biomedical research enterprise.

The NIH HEAL initiative

(Wednesday, May 2, 2018)
As the Nation’s medical research agency, one of NIH’s most important roles is leveraging our resources to respond to emerging public health crises.

Highlighting NINDS contributions to treatments for neurological disorders

(Friday, February 9, 2018)
The toll that neurological disorders exact on patients and their families is truly tragic. Yet, looking forward there is cause for real optimism for some conditions.

NINDS: A Look Back at 2017

(Wednesday, January 31, 2018)
The beginning of a new year has a way of sneaking up on all of us, but we always gain helpful perspectives by stopping to reflect on the year that has passed. In 2017, NINDS made significant strides through funding awards, collaboration, new research initiatives, and leadership additions.

Looking Forward to Serving as NINDS Deputy Director!

(Thursday, January 18, 2018)
By: Nina Schor, NINDS Deputy Director

Help us promote your stories of discovery

(Wednesday, January 3, 2018)
I’m a news junkie, and I love stories, especially those about science. You may not realize it, but every day as part of the NINDS research community, you are generating incredible news.

Neuroscientists, Welcome to Washington!

(Friday, November 10, 2017)
This week, more than thirty thousand neuroscientists are coming to Washington, DC for the annual meeting of the Society for Neuroscience (SfN).

Boosting Research on Alzheimer’s Disease and Related Dementias (AD/ADRD)

(Monday, October 30, 2017)
If you know anyone with dementia, you probably understand how devastating it is to those affected and their families. Alzheimer’s Disease (AD), the most common and widely-diagnosed neurodegenerative disorder, affects more than 5 million people in the United States.

Pages